Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028

Globe Newswire - Mon Jul 18, 2022

-- Growth to benefit ABVC’s Vitargus medical device product --

FREMONT, CA, July 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that, according to a recent study by Bosson Research, the global Retinal Surgical Instruments market, valued at USD 1.59 billion in 2021, is expected to reach USD2.46 billion by the end of 2028, growing at a CAGR of 6.08% between 2022 and 2028. This growth is expected to benefit ABVC’s development of its medical device, Vitargus, a gel-like substance that aims to help the eye maintain a round shape and keep the retina in place during and after retina re-attachment surgery.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada

The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings

international business

Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks

investor newsletter

The key to successful investing. Plus, why Fairfax Financial is poised for an extraordinary run

The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive

inside the market

Tuesday’s analyst upgrades and downgrades

The close: Major indexes fall after wage data; cannabis shares surge on U.S. regulatory move

The close: Stocks higher as investors focus on Fed moves